Sidney Kimmel Comprehensive Cancer Center at John Hopkins

Baltimore, Maryland 21287

2 studies enrolling now · 8 studies all time

What they study most

Biliary Tract Cancer, Cholangiocarcinoma, ER+ Breast Cancer, Extrapulmonary Neuroendocrine Carcinoma (EP-NEC), Follicular Lymphoma, Gallbladder Cancer, Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC), Large Cell Neuroendocrine Cancer (LCNEC), Metastatic Castration Resistant Prostate Cancer, Metastatic Soft Tissue Sarcoma, Neuroendocrine Carcinomas (NEC), Neuroendocrine Prostate Cancer (NEPC)

Studies at this site

• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) — Recruiting now
• Circulating Tumor DNA — Recruiting now
• Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy — Completed
• Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC — Stopped early
• M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) — Completed
• To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer — Stopped early
• Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation — Completed
• Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC — Completed